Pten Dose Dictates Cancer Progression in the Prostate
Complete inactivation of the PTEN tumor suppressor gene is extremely common in advanced cancer, including prostate cancer (CaP). However, one PTEN allele is already lost in the vast majority of CaPs at presentation. To determine the consequence of PTEN dose variations on cancer progression, we have...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2003
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC270016/ |